FDA Adverse Event Malfunction Summary report: N

COBAS 8000 C701 MODULE

MDR report key: 3172569 · Received June 17, 2013

Report

Report Number
1823260-2013-03613
Event Type
Malfunction
Date Received
June 17, 2013
Date of Event
May 15, 2013
Report Date
September 27, 2013
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JJE
PMA / PMN Number
K100853
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
MEDICAL TECHNOLOGIST

Narratives

Additional Manufacturer Narrative · 1

IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.

Additional Manufacturer Narrative · 1

DUE TO THE LACK OF DATA AND INFORMATION FROM THE CUSTOMER, A SPECIFIC ROOT CAUSE COULD NOT BE DETERMINED. SINCE MULTIPLE MODULES OF THE ANALYZER WERE INVOLVED, A SAMPLE SPECIFIC ISSUE WAS THE MOST LIKELY CAUSE.

Description of Event or Problem · 1

THE CUSTOMER RECEIVED QUESTIONABLE RESULTS FOR MULTIPLE ASSAYS FOR ONE PATIENT SAMPLE. OF THE DATA PROVIDED, ONLY THE RESULTS FOR CALCIUM, GLUCOSE, TOTAL PROTEIN AND ASPARTATE AMINOTRANSFERASE (AST) WERE DISCREPANT AND REPORTED OUTSIDE THE LABORATORY. THE INITIAL CALCIUM RESULT WAS 6.6 MG/DL AND THE REPEAT RESULT WAS 9.9 MG/DL. THE INITIAL GLUCOSE RESULT WAS 58 MG/DL AND THE REPEAT RESULT WAS 82 MG/DL. THE INITIAL TOTAL PROTEIN RESULT WAS 4.9 G/DL AND THE REPEAT RESULT WAS 7.1 G/DL. THE INITIAL AST RESULT WAS 14 U/L AND REPEAT RESULT WAS 22 U/L. THE REPEAT RESULTS WERE BELIEVED TO BE CORRECT. THE PATIENT WAS NOT ADVERSELY AFFECTED. THE CALCIUM REAGENT LOT NUMBER WAS 67213601 WITH AN EXPIRATION DATE OF 11/30/2013. THE GLUCOSE REAGENT LOT NUMBER WAS 66901201 WITH AN EXPIRATION DATE OF 11/30/2013. THE TOTAL PROTEIN REAGENT LOT NUMBER WAS 67424801 WITH AN EXPIRATION DATE OF 03/31/2014. THE AST REAGENT LOT NUMBER WAS 67113901 WITH AN EXPIRATION DATE OF 01/31/2014. THE CUSTOMER DECLINED A SERVICE VISIT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
273861 COBAS 8000 C701 MODULE CLINICAL CHEMISTRY ANALYZER JJE ROCHE DIAGNOSTICS NA NA

Patients

Seq Age Sex Outcome Treatment
1